Tracy Rosky Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
Mr. Jin S. Jang Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4000 Chemical Rd, Ste #100, Plymouth Meeting, PA 19462 Phone: 800-548-9903 Fax: 610-941-0742 |
Robin M Libowitz Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
Robert Mikhail Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
Angela Michele Stanton, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
Patricia A. Backeris Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
Mia Wyatt Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
Mrs. Chioma Joyce Ohiri, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 800-879-4471 Fax: 610-834-7525 |
Jerome Silberman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 800-879-4471 |
Sarah Atas, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
Mr. Anthony Joseph Colega, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 412-278-0557 |
Leo Hegner Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 800-879-4471 |
Kathy J Hogan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
Lawrence Maiolo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 800-879-4471 |
James Tarloff Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
Mrs. Jean Roma Abrams, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 142 Woodbine Way, Plymouth Meeting, PA 19462 Phone: 610-608-5107 |
Manzoor Sheikh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
James Tancredi Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
Solomon Maduko Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
Chinedu Momah Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |
News Archive
Extremely premature babies run a much higher risk of developing autism in later childhood, and even during the neonate period differences are seen in the brains of those who do. This according to a new study by researchers from Karolinska Institutet and Karolinska University Hospital in Sweden.
In a speech delivered at the XIX International AIDS Conference in Washington, D.C., on Monday, U.S. Secretary of State Hillary Clinton "underscored the United States' commitment to achieving an 'AIDS-free generation' and announced more than $150 million in additional funding," Politico reports.
In a study that included more than 10,000 men with nonmetastatic prostate cancer, use of androgen deprivation therapy (ADT) was associated with a significantly increased risk of acute kidney injury, with variations observed with certain types of ADTs, according to a study in the July 17 issue of JAMA.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE).
Researchers at the University of the Basque Country (UPV/EHU) and the Achucarro neurosciences centre have discovered a new therapy for the fragile X chromosome syndrome. This new therapy proposes the modulation of the cerebral endocannabinoid system in order to ameliorate the symptoms of the disease.
› Verified 9 days ago